GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSS) » Definitions » ROE % Adjusted to Book Value

STSS (Sharps Technology) ROE % Adjusted to Book Value : -114.22% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sharps Technology ROE % Adjusted to Book Value?

Sharps Technology's ROE % for the quarter that ended in Sep. 2024 was -98.23%. Sharps Technology's PB Ratio for the quarter that ended in Sep. 2024 was 0.86. Sharps Technology's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -114.22%.


Sharps Technology ROE % Adjusted to Book Value Historical Data

The historical data trend for Sharps Technology's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharps Technology ROE % Adjusted to Book Value Chart

Sharps Technology Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -61.55 -140.00

Sharps Technology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.85 -167.40 -68.08 -125.74 -114.22

Competitive Comparison of Sharps Technology's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Sharps Technology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sharps Technology's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sharps Technology's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sharps Technology's ROE % Adjusted to Book Value falls into.



Sharps Technology ROE % Adjusted to Book Value Calculation

Sharps Technology's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-112.00% / 0.80
=-140.00%

Sharps Technology's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-98.23% / 0.86
=-114.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sharps Technology ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sharps Technology's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sharps Technology Business Description

Traded in Other Exchanges
N/A
Address
105 Maxess Road, Suite 124, Melville, NY, USA, 11747
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
Executives
Robert Michael Hayes director, officer: Chief Executive Officer 75 BROOKSHIRE DRIVE, YOUNGSVILLE NC 27596
Andrew R. Crescenzo officer: Chief Financial Officer C/O ENZO BIOCHEM, 527 MADISON AVENUE, NEW YORK NY 10022
Timothy James Ruemler director 3311 RIVERPARK CT., BENITA SPRINGS FL 34134
Alan R. Blackman director, officer: CIO and COO 11502 ROBLES DR. REPP PLACE, TEMPLE TERRACE FL 33617
Paul K Danner director
Soren Bo Christiansen director 4059 SPRING VALLEY ROAD, DOYLESTOWN PA 18902
Brenda Baird Simpson director 7336 PRAIRIE STAR COURT,, PARKER CO 80134
Jason L. Monroe director 14527 LINDALE ROSE LANE, HUMBLE TX 77379
Barry Boris Berler officer: CTO and Inventor 77 HERZL STREET, RAMAT GAN L3 5244352

Sharps Technology Headlines